Launch of Asia Pacific Consortium on Osteoporosis

The consortium aims to develop solutions to pressing challenges facing osteoporosis management and fracture prevention in the world's most populous region.

On May 4, 2019, the Asia Pacific Consortium on Osteoporosis (APCO) was launched at a meeting in Singapore. The meeting was attended by 24 clinical experts from across the Asia Pacific region. The consortium aims to develop solutions to pressing challenges facing osteoporosis management and fracture prevention in this highly populous part of the world.

Dr. Manju Chandran, APCO Chairperson and Senior Consultant Endocrinologist and Director of the Osteoporosis and Bone Metabolism Unit at Singapore General Hospital, said

Asia Pacific is home to 60% of the world’s population, and that population is ageing fast, so we are facing a surge in the incidence of debilitating fractures caused by osteoporosis in the coming decades”.

During the last 30 years, considerable progress has been made in the development of technology and tools to diagnose osteoporosis and assess fracture risk. Furthermore, a plethora of osteoporosis treatments is now available throughout the world. These medications have been shown to significantly reduce fracture risk among those affected. However, a growing body of evidence suggests that there is much work to be done to ensure that the right patient receives the right intervention at the right time.

The primary purpose of APCO is to support healthcare professionals to deliver best practice for people who are living with osteoporosis. “The diversity of the APCO membership is a great strength, as it creates a forum for the exchange of ideas between experts working in very different healthcare systems and clinical settings” said Dr. Chandran. “As such”, she stated, “the initial aim of APCO will be to develop comprehensive Pan-Asia Pacific guidance and promulgate basic standards of care for risk assessment, diagnosis and management of osteoporosis and its dreaded complication of fragility fractures. These standards could subsequently be adapted for use within countries across the region”.

The International Osteoporosis Foundation (IOF) was represented at the APCO launch by Dr. Philippe Halbout, IOF Chief Executive Officer.

The United Nations has projected that the population aged 65 years and over in Asia is set to increase from 411 million in 2020 to 582 million in 2030, and 937 million in 20501. Consequently, determined efforts are required to avoid an epidemiological emergency unfolding across this region during our lifetimes, and IOF wholeheartedly supports APCO’s commitment to drive much needed change”.

1. United Nations Department of Economic and Social Affairs Population Division. World Population Prospects: the 2017 revision. Volume I: comprehensive tables (ST/ESA/SER.A/399). New York 2017.

The Asia Pacific Consortium on Osteoporosis (APCO) wishes to acknowledge Amgen Asia for their provision of financial support to fund a secretariat function, event management and communication activities leading up to the formation of APCO. However, the opinions and activities of APCO are not influenced by Amgen, nor did Amgen have any role in the development of this media announcement.